Шифр: CS7/2008/22/4 Журнал 2008р. Vol. 22 N 4 Bahlmann, F. H. Use of Erythropoietin for Cardiovascular Protection / F. H. Bahlmann. - P.253-255 Riksen, N. P. Wake Up and Smell the Coffee: Yet Another No Go for Cardiac Patients? : Editorial to “Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins Against Ischemia–reperfusion Injury in the Rat” by Ye et al / N. P. Riksen, D. J. Hausenloy, D. M. Yellon. - P.257-259 Boer, R. A. de ACE-inhibitors, Beta-blockers or the Combination in Heart Failure: Is It Just an A–B–C? : EDITORIAL to: Effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al / R. A. de Boer, D. J. van Veldhuisen. - P.261-263 Erythropoietin Stimulates Normal Endothelial Progenitor Cell-Mediated Endothelial Turnover, but Attributes to Neovascularization Only in the Presence of Local Ischemia. - P.265-274 Інші автори: Westenbrink B. D., Oeseburg H., Lin Y., Manickavasagam S., Hughes M. G., McAdoo D. J., Perez-Polo R. J., Birnbaum Y. Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins against Ischemia–Reperfusion Injury in the Rat. - P.275-282 Інші автори: Ye Y., Abu S. G. H., Lin Y., Manickavasagam S., Hughes M. G., McAdoo D. J., Perez-Polo R. J., Birnbaum Y. Antiapoptosis and Mitochondrial Effect of Pioglitazone Preconditioning in the Ischemic/reperfused Heart of Rat. - P.283-291 Інші автори: Li J., Lang M.-J., Mao X.-B., Tian L., Feng Y.-B. Administration of the Rho-Kinase Inhibitor Fasudil Before Ischemia or just After Reperfusion, but not 30 min After Reperfusion, Protects the Stunned Myocardium in Swine. - P.293-298 Інші автори: Shibata I., Yoshitomi O., Use T., Ureshino H., Cho S., Maekawa T., Hara T., Sumikawa K. Effects of Folic Acid on Cardiac Myocyte Apoptosis in Rats with Streptozotocin-induced Diabetes Mellitus. - P.299-304 Інші автори: Wu T.-G., Li W.-H., Lin Z.-Q., Wang L.-X. Effect of Beta-blockade and ACE Inhibition on B-type Natriuretic Peptides in Stable Patients with Systolic Heart Failure. - P.305-311 Інші автори: Rosenberg J., Gustafsson F., Remme W. J., Riegger G. A. J., Rossen H. P. Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design. - P.313-320 Інші автори: Valgimigli M., Campo G., Cesare N. de, Vranckx P., Hamon M., Angiolillo D. J., Sabate M., Ferrari F., Furgieri A., Tumscitz C., Repetto A., Colangelo S., Meliga E., Kubbajeh M., Parrinello G., Percoco G., Ferrari R. McTaggart, F. Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit / F. McTaggart, P. Jones. - P.321-338 Є примірники у відділах: всього 1 : ВКТ (1) Вільні: ВКТ (1) |